Yasuda T, Yanagi T, Mokuno K, Kato K
Department of Neurology, Nagoya Daini Red Cross Hospital.
Rinsho Shinkeigaku. 1992 Nov;32(11):1299-301.
We have previously reported that NSE and S-100b protein (S-100) could be used as reliable markers to evaluate the damage of the spinal cord in cervical spondylosis (CS) and ossification of posterior longitudinal ligament (OPLL). In the present study we made MRI in 21 patients with CS. There was a positive correlation between the NSE level in CSF and the degree of the spinal cord compression shown by MRI. In 10 cases of CS we examined these specific protein levels in CSF before and after the Glisson's traction therapy for one month. In seven of them the NSE levels decreased with the clinical improvements. On the other hand, 2 cases showed the rise of NSE levels after the traction. One of them became clinically worse during the therapy, while in another case the NSE levels changed within the normal range. The level of NSE in the other case was unchanged. In 57-year-old patient with CS myelopathy we examined the NSE levels chronologically. The NSE level changed in parallel with his clinical features. We suggest that NSE level in CSF may be a useful marker to estimate the change of the degree of the spinal cord damage in CS.
我们之前曾报道,神经元特异性烯醇化酶(NSE)和S-100b蛋白(S-100)可作为评估颈椎病(CS)和后纵韧带骨化症(OPLL)中脊髓损伤的可靠标志物。在本研究中,我们对21例CS患者进行了磁共振成像(MRI)检查。脑脊液中NSE水平与MRI所示脊髓受压程度之间存在正相关。在10例CS患者中,我们在进行为期1个月的Glisson牵引治疗前后检测了脑脊液中这些特定蛋白的水平。其中7例患者的NSE水平随临床症状改善而降低。另一方面,2例患者在牵引后NSE水平升高。其中1例在治疗期间临床症状恶化,而在另一例中,NSE水平在正常范围内变化。另一例患者的NSE水平未变。我们对一名57岁的CS脊髓病患者按时间顺序检测了NSE水平。NSE水平与他的临床症状平行变化。我们认为,脑脊液中NSE水平可能是评估CS中脊髓损伤程度变化的有用标志物。